サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121153

世界の黄斑変性治療市場：考察と予測 (2028年まで)

Global Macular Degeneration Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
世界の黄斑変性治療市場：考察と予測 (2028年まで)
出版日: 2022年09月01日
発行: QYResearch
ページ情報: 英文 113 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、黄斑変性治療 (Macular Degeneration Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の黄斑変性治療の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Lucentis
    • Eylea
    • Avastin
    • Others
  • 市場：アプリケーション別
    • 世界の黄斑変性治療の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Eye Clinics
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の黄斑変性治療の市場展望 (2017-2028)
  • 黄斑変性治療の市場成長トレンド：地域別
    • 黄斑変性治療 市場規模：地域別: 2017 VS 2021 VS 2028
    • 黄斑変性治療の市場規模実績：地域別 (2017-2022)
    • 黄斑変性治療の市場規模予測：地域別 (2023-2028)
  • 黄斑変性治療 市場動向
    • 黄斑変性治療 業界動向
    • 黄斑変性治療 市場の促進要因
    • 黄斑変性治療 市場の課題
    • 黄斑変性治療 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の黄斑変性治療の上位企業：収益別
    • 世界の黄斑変性治療の上位企業：収益別 (2017-2022)
    • 世界の黄斑変性治療の収益シェア：企業別 (2017-2022)
  • 世界の黄斑変性治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：黄斑変性治療の収益
  • 世界の黄斑変性治療 市場集中度
    • 世界の黄斑変性治療 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 黄斑変性治療の収益 2021
  • 黄斑変性治療の主要企業の本社および事業エリア
  • 主要企業 黄斑変性治療の製品ソリューションおよびサービス
  • 市場参入時期： 黄斑変性治療 市場
  • M&A, 拡張計画

第4章 黄斑変性治療 内訳データ：タイプ別

  • 世界の黄斑変性治療の市場規模実績：タイプ別 (2017-2022)
  • 世界の黄斑変性治療の市場規模予測：タイプ別 (2023-2028)

第5章 黄斑変性治療 内訳データ：アプリケーション別

  • 世界の黄斑変性治療の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の黄斑変性治療の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の黄斑変性治療 市場規模 (2017-2028)
  • 北米の黄斑変性治療 市場規模：タイプ別
    • 北米の黄斑変性治療 市場規模：タイプ別 (2017-2022)
    • 北米の黄斑変性治療 市場規模：タイプ別 (2023-2028)
    • 北米の黄斑変性治療の市場シェア：タイプ別 (2017-2028)
  • 北米の黄斑変性治療 市場規模：アプリケーション別
    • 北米の黄斑変性治療 市場規模：アプリケーション別 (2017-2022)
    • 北米の黄斑変性治療 市場規模：アプリケーション別 (2023-2028)
    • 北米の黄斑変性治療の市場シェア：アプリケーション別 (2017-2028)
  • 北米の黄斑変性治療 市場規模：国別
    • 北米の黄斑変性治療 市場規模：国別 (2017-2022)
    • 北米の黄斑変性治療 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の黄斑変性治療 市場規模 (2017-2028)
  • 欧州の黄斑変性治療 市場規模：タイプ別
    • 欧州の黄斑変性治療 市場規模：タイプ別 (2017-2022)
    • 欧州の黄斑変性治療 市場規模：タイプ別 (2023-2028)
    • 欧州の黄斑変性治療の市場シェア：タイプ別 (2017-2028)
  • 欧州の黄斑変性治療 市場規模：アプリケーション別
    • 欧州の黄斑変性治療 市場規模：アプリケーション別 (2017-2022)
    • 欧州の黄斑変性治療 市場規模：アプリケーション別 (2023-2028)
    • 欧州の黄斑変性治療の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の黄斑変性治療 市場規模：国別
    • 欧州の黄斑変性治療 市場規模：国別 (2017-2022)
    • 欧州の黄斑変性治療 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 黄斑変性治療 市場規模 (2017-2028)
  • アジア太平洋地域 黄斑変性治療 市場規模：タイプ別
    • アジア太平洋地域 黄斑変性治療 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 黄斑変性治療 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 黄斑変性治療の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 黄斑変性治療 市場規模：アプリケーション別
    • アジア太平洋地域 黄斑変性治療 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 黄斑変性治療 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 黄斑変性治療の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 黄斑変性治療 市場規模：地域別
    • アジア太平洋地域 黄斑変性治療 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 黄斑変性治療 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの黄斑変性治療 市場規模 (2017-2028)
  • ラテンアメリカの黄斑変性治療 市場規模：タイプ別
    • ラテンアメリカの黄斑変性治療 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの黄斑変性治療 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの黄斑変性治療の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの黄斑変性治療 市場規模：アプリケーション別
    • ラテンアメリカの黄斑変性治療 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの黄斑変性治療 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの黄斑変性治療の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの黄斑変性治療 市場規模：国別
    • ラテンアメリカの黄斑変性治療 市場規模：国別 (2017-2022)
    • ラテンアメリカの黄斑変性治療 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの黄斑変性治療 市場規模 (2017-2028)
  • 中東・アフリカの黄斑変性治療 市場規模：タイプ別
    • 中東・アフリカの黄斑変性治療 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの黄斑変性治療 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの黄斑変性治療の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの黄斑変性治療 市場規模：アプリケーション別
    • 中東・アフリカの黄斑変性治療 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの黄斑変性治療 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの黄斑変性治療の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの黄斑変性治療 市場規模：国別
    • 中東・アフリカの黄斑変性治療 市場規模：国別 (2017-2022)
    • 中東・アフリカの黄斑変性治療 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Bausch Health Companies
  • Allergan
  • Novartis
  • Pfizer
  • Bayer
  • Roche
  • Sanofi
  • Santen Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Kanghong Pharma

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Lucentis
  • Table 3. Key Players of Eylea
  • Table 4. Key Players of Avastin
  • Table 5. Key Players of Others
  • Table 6. Global Macular Degeneration Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Macular Degeneration Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Macular Degeneration Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Macular Degeneration Treatment Market Share by Region (2017-2022)
  • Table 10. Global Macular Degeneration Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Macular Degeneration Treatment Market Share by Region (2023-2028)
  • Table 12. Macular Degeneration Treatment Market Trends
  • Table 13. Macular Degeneration Treatment Market Drivers
  • Table 14. Macular Degeneration Treatment Market Challenges
  • Table 15. Macular Degeneration Treatment Market Restraints
  • Table 16. Global Macular Degeneration Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Macular Degeneration Treatment Revenue Share by Players (2017-2022)
  • Table 18. Global Top Macular Degeneration Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2021)
  • Table 19. Ranking of Global Top Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Macular Degeneration Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Macular Degeneration Treatment Product Solution and Service
  • Table 23. Date of Enter into Macular Degeneration Treatment Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Macular Degeneration Treatment Revenue Market Share by Type (2017-2022)
  • Table 27. Global Macular Degeneration Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Macular Degeneration Treatment Revenue Market Share by Type (2023-2028)
  • Table 29. Global Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Macular Degeneration Treatment Revenue Share by Application (2017-2022)
  • Table 31. Global Macular Degeneration Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Macular Degeneration Treatment Revenue Share by Application (2023-2028)
  • Table 33. North America Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Macular Degeneration Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Macular Degeneration Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Macular Degeneration Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Macular Degeneration Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Macular Degeneration Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Macular Degeneration Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Macular Degeneration Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Macular Degeneration Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Macular Degeneration Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Macular Degeneration Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Macular Degeneration Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Macular Degeneration Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Macular Degeneration Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Macular Degeneration Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Macular Degeneration Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Macular Degeneration Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Macular Degeneration Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Macular Degeneration Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Macular Degeneration Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Macular Degeneration Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Macular Degeneration Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Macular Degeneration Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Bausch Health Companies Company Details
  • Table 64. Bausch Health Companies Business Overview
  • Table 65. Bausch Health Companies Macular Degeneration Treatment Product
  • Table 66. Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 67. Bausch Health Companies Recent Developments
  • Table 68. Allergan Company Details
  • Table 69. Allergan Business Overview
  • Table 70. Allergan Macular Degeneration Treatment Product
  • Table 71. Allergan Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 72. Allergan Recent Developments
  • Table 73. Novartis Company Details
  • Table 74. Novartis Business Overview
  • Table 75. Novartis Macular Degeneration Treatment Product
  • Table 76. Novartis Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 77. Novartis Recent Developments
  • Table 78. Pfizer Company Details
  • Table 79. Pfizer Business Overview
  • Table 80. Pfizer Macular Degeneration Treatment Product
  • Table 81. Pfizer Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 82. Pfizer Recent Developments
  • Table 83. Bayer Company Details
  • Table 84. Bayer Business Overview
  • Table 85. Bayer Macular Degeneration Treatment Product
  • Table 86. Bayer Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 87. Bayer Recent Developments
  • Table 88. Roche Company Details
  • Table 89. Roche Business Overview
  • Table 90. Roche Macular Degeneration Treatment Product
  • Table 91. Roche Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 92. Roche Recent Developments
  • Table 93. Sanofi Company Details
  • Table 94. Sanofi Business Overview
  • Table 95. Sanofi Macular Degeneration Treatment Product
  • Table 96. Sanofi Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 97. Sanofi Recent Developments
  • Table 98. Santen Pharmaceuticals Company Details
  • Table 99. Santen Pharmaceuticals Business Overview
  • Table 100. Santen Pharmaceuticals Macular Degeneration Treatment Product
  • Table 101. Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 102. Santen Pharmaceuticals Recent Developments
  • Table 103. Regeneron Pharmaceuticals Company Details
  • Table 104. Regeneron Pharmaceuticals Business Overview
  • Table 105. Regeneron Pharmaceuticals Macular Degeneration Treatment Product
  • Table 106. Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 107. Regeneron Pharmaceuticals Recent Developments
  • Table 108. Kanghong Pharma Company Details
  • Table 109. Kanghong Pharma Business Overview
  • Table 110. Kanghong Pharma Macular Degeneration Treatment Product
  • Table 111. Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2017-2022) & (US$ Million)
  • Table 112. Kanghong Pharma Recent Developments
  • Table 113. Research Programs/Design for This Report
  • Table 114. Key Data Information from Secondary Sources
  • Table 115. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Macular Degeneration Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Lucentis Features
  • Figure 3. Eylea Features
  • Figure 4. Avastin Features
  • Figure 5. Others Features
  • Figure 6. Global Macular Degeneration Treatment Market Share by Application: 2021 VS 2028
  • Figure 7. Hospitals Case Studies
  • Figure 8. Eye Clinics Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Macular Degeneration Treatment Report Years Considered
  • Figure 11. Global Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Macular Degeneration Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Macular Degeneration Treatment Market Share by Region: 2021 VS 2028
  • Figure 14. Global Macular Degeneration Treatment Market Share by Players in 2021
  • Figure 15. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Macular Degeneration Treatment Revenue in 2021
  • Figure 17. North America Macular Degeneration Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Macular Degeneration Treatment Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Macular Degeneration Treatment Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Macular Degeneration Treatment Market Size Share by Country (2017-2028)
  • Figure 21. United States Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Macular Degeneration Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Macular Degeneration Treatment Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Macular Degeneration Treatment Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Macular Degeneration Treatment Market Size Share by Country (2017-2028)
  • Figure 27. Germany Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Macular Degeneration Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Macular Degeneration Treatment Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Macular Degeneration Treatment Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Macular Degeneration Treatment Market Size Share by Region (2017-2028)
  • Figure 37. China Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 43. Latin America Macular Degeneration Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Macular Degeneration Treatment Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Macular Degeneration Treatment Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Macular Degeneration Treatment Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Macular Degeneration Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Macular Degeneration Treatment Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Macular Degeneration Treatment Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Macular Degeneration Treatment Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Macular Degeneration Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Bausch Health Companies Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 57. Allergan Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 58. Novartis Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 59. Pfizer Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 60. Bayer Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 61. Roche Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 62. Sanofi Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 63. Santen Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 65. Kanghong Pharma Revenue Growth Rate in Macular Degeneration Treatment Business (2017-2022)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed
目次

This research report focuses on the Macular Degeneration Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Lucentis
    • 1.2.3 Eylea
    • 1.2.4 Avastin
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Macular Degeneration Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Eye Clinics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Macular Degeneration Treatment Market Perspective (2017-2028)
  • 2.2 Macular Degeneration Treatment Growth Trends by Region
    • 2.2.1 Macular Degeneration Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Macular Degeneration Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Macular Degeneration Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Macular Degeneration Treatment Market Dynamics
    • 2.3.1 Macular Degeneration Treatment Industry Trends
    • 2.3.2 Macular Degeneration Treatment Market Drivers
    • 2.3.3 Macular Degeneration Treatment Market Challenges
    • 2.3.4 Macular Degeneration Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Macular Degeneration Treatment Players by Revenue
    • 3.1.1 Global Top Macular Degeneration Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Macular Degeneration Treatment Revenue
  • 3.4 Global Macular Degeneration Treatment Market Concentration Ratio
    • 3.4.1 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Macular Degeneration Treatment Revenue in 2021
  • 3.5 Macular Degeneration Treatment Key Players Head office and Area Served
  • 3.6 Key Players Macular Degeneration Treatment Product Solution and Service
  • 3.7 Date of Enter into Macular Degeneration Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Macular Degeneration Treatment Breakdown Data by Type

  • 4.1 Global Macular Degeneration Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Macular Degeneration Treatment Forecasted Market Size by Type (2023-2028)

5 Macular Degeneration Treatment Breakdown Data by Application

  • 5.1 Global Macular Degeneration Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Macular Degeneration Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Macular Degeneration Treatment Market Size (2017-2028)
  • 6.2 North America Macular Degeneration Treatment Market Size by Type
    • 6.2.1 North America Macular Degeneration Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Macular Degeneration Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Macular Degeneration Treatment Market Share by Type (2017-2028)
  • 6.3 North America Macular Degeneration Treatment Market Size by Application
    • 6.3.1 North America Macular Degeneration Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Macular Degeneration Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Macular Degeneration Treatment Market Share by Application (2017-2028)
  • 6.4 North America Macular Degeneration Treatment Market Size by Country
    • 6.4.1 North America Macular Degeneration Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Macular Degeneration Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Macular Degeneration Treatment Market Size (2017-2028)
  • 7.2 Europe Macular Degeneration Treatment Market Size by Type
    • 7.2.1 Europe Macular Degeneration Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Macular Degeneration Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Macular Degeneration Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Macular Degeneration Treatment Market Size by Application
    • 7.3.1 Europe Macular Degeneration Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Macular Degeneration Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Macular Degeneration Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Macular Degeneration Treatment Market Size by Country
    • 7.4.1 Europe Macular Degeneration Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Macular Degeneration Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Macular Degeneration Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Macular Degeneration Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Macular Degeneration Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Macular Degeneration Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Macular Degeneration Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Macular Degeneration Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Macular Degeneration Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Macular Degeneration Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Macular Degeneration Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Macular Degeneration Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Macular Degeneration Treatment Market Size (2017-2028)
  • 9.2 Latin America Macular Degeneration Treatment Market Size by Type
    • 9.2.1 Latin America Macular Degeneration Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Macular Degeneration Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Macular Degeneration Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Macular Degeneration Treatment Market Size by Application
    • 9.3.1 Latin America Macular Degeneration Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Macular Degeneration Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Macular Degeneration Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Macular Degeneration Treatment Market Size by Country
    • 9.4.1 Latin America Macular Degeneration Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Macular Degeneration Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Macular Degeneration Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Macular Degeneration Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Macular Degeneration Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Macular Degeneration Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Macular Degeneration Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Macular Degeneration Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Macular Degeneration Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Macular Degeneration Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Macular Degeneration Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Macular Degeneration Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bausch Health Companies
    • 11.1.1 Bausch Health Companies Company Details
    • 11.1.2 Bausch Health Companies Business Overview
    • 11.1.3 Bausch Health Companies Macular Degeneration Treatment Introduction
    • 11.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.1.5 Bausch Health Companies Recent Developments
  • 11.2 Allergan
    • 11.2.1 Allergan Company Details
    • 11.2.2 Allergan Business Overview
    • 11.2.3 Allergan Macular Degeneration Treatment Introduction
    • 11.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.2.5 Allergan Recent Developments
  • 11.3 Novartis
    • 11.3.1 Novartis Company Details
    • 11.3.2 Novartis Business Overview
    • 11.3.3 Novartis Macular Degeneration Treatment Introduction
    • 11.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.3.5 Novartis Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Macular Degeneration Treatment Introduction
    • 11.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.4.5 Pfizer Recent Developments
  • 11.5 Bayer
    • 11.5.1 Bayer Company Details
    • 11.5.2 Bayer Business Overview
    • 11.5.3 Bayer Macular Degeneration Treatment Introduction
    • 11.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.5.5 Bayer Recent Developments
  • 11.6 Roche
    • 11.6.1 Roche Company Details
    • 11.6.2 Roche Business Overview
    • 11.6.3 Roche Macular Degeneration Treatment Introduction
    • 11.6.4 Roche Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.6.5 Roche Recent Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Company Details
    • 11.7.2 Sanofi Business Overview
    • 11.7.3 Sanofi Macular Degeneration Treatment Introduction
    • 11.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.7.5 Sanofi Recent Developments
  • 11.8 Santen Pharmaceuticals
    • 11.8.1 Santen Pharmaceuticals Company Details
    • 11.8.2 Santen Pharmaceuticals Business Overview
    • 11.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Introduction
    • 11.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.8.5 Santen Pharmaceuticals Recent Developments
  • 11.9 Regeneron Pharmaceuticals
    • 11.9.1 Regeneron Pharmaceuticals Company Details
    • 11.9.2 Regeneron Pharmaceuticals Business Overview
    • 11.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Introduction
    • 11.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.9.5 Regeneron Pharmaceuticals Recent Developments
  • 11.10 Kanghong Pharma
    • 11.10.1 Kanghong Pharma Company Details
    • 11.10.2 Kanghong Pharma Business Overview
    • 11.10.3 Kanghong Pharma Macular Degeneration Treatment Introduction
    • 11.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2017-2022)
    • 11.10.5 Kanghong Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer